Fludeoxyglucose F 18 Injection, Solution
Product Images NDC 60055-334

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Fludeoxyglucose F 18 (NDC 60055-334). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Jubilant Draximage Inc., Dba Jubilant Radiopharma, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fludeoxyglucose F 18 Injection

Fludeoxyglucose F 18 Injection multiple-dose vial label showing sterile, non-pyrogenic solution with concentration ranging from 20 mCi/mL to 300 mCi/mL at end of synthesis. Label includes calibration details, expiration time (12 hours after EOS), storage instructions at 25°C, and usage directions for intravenous diagnostic use only. Manufactured by Jubilant Radiopharma, Yardley, PA. Caution indicated for radioactive material.*

FDA Label Image

Image Description (Fludeoxyglucose 01)

Chemical structure of Fludeoxyglucose F-18 showing the molecular arrangement of atoms, including carbon, hydrogen, oxygen, and fluorine-18 isotope, depicted in a standard chemical diagram format.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.